Latest Stock Split Details
Key information about Lumos Pharma, Inc.'s most recent stock split
Split Date: 2020-03-19
Split Ratio: 1:9
Price Before Split: $0.97
Price After Split: $0.11
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 9.00 times fewer shares (a 1:9 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of Lumos Pharma, Inc.'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2020-03-19 | 1:9 | Yes | $0.97 | $0.11 |
About Lumos Pharma, Inc.
Company overview and industry information
Lumos Pharma, Inc. (LUMO) operates in the Biotechnology industry. The recent 1-for-9 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.
Biotechnology
Go to Lumos Pharma, Inc. Summary